May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Very-Long-Chain Fatty Acids and Macular Carotenoid Metabolites Are Biomarkers of Age-Related Macular Degeneration
Author Affiliations & Notes
  • P. Bhosale
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah
  • B. Serban
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah
  • P. S. Bernstein
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah
  • Footnotes
    Commercial Relationships P. Bhosale, None; B. Serban, None; P.S. Bernstein, None.
  • Footnotes
    Support NIH EY 11600; Steinbach Foundation; Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 2142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Bhosale, B. Serban, P. S. Bernstein; Very-Long-Chain Fatty Acids and Macular Carotenoid Metabolites Are Biomarkers of Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2007;48(13):2142.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Lipophilic nutritional factors such as omega-3 fatty acids and carotenoids exert several important biological effects that may protect against retinal degenerative diseases such as age-related macular degeneration (AMD). The upcoming Age-Related Eye Disease Study II (AREDS II) is specifically focusing on the potential protective roles of the macular carotenoids and omega-3 fatty acids; however, experimental and epidemiological data to date have not clearly established the major biochemical mechanisms behind the protective effect of these molecules.

Methods:: Macula, peripheral retina, and retinal pigment epithelium (RPE) samples (all 8-mm punches) from 19 donor eyes with a history of AMD and 21 age-matched normal donors were procured from the local eye bank. Carotenoid and fatty acid profiles were determined by HPLC or GC coupled with in-line single quadrupole mass spectrometers (MS), respectively.

Results:: A) Carotenoids: We observed lower levels of total macular carotenoids (18.8 ±7.2 ng, n=19) relative to age-matched normals (28.4 ±12.6 ng, n=21). 3-Methoxyzeaxanthin (3-MZ), a macula specific zeaxanthin metabolite, was higher in the AMD donor eyes (4.1 ±4.7, n=19) in comparison to age matched donors (1.9 ±1.3, n=21, p < 0.001). B) Total fatty acids: We observed similar distributions of myristic (C14), palmitic (C16), stearic (C18), oleic (C18:1 (n-6)), linoleic (C18:2 (n-6)), and arachidonic (C20:4 (n-6)) fatty acids in AMD and age-matched donor retinas. Retinas of AMD donor eyes had significantly less docosahexaenoic acid (DHA, C22:6 (n-3)) in comparison to normal donors. The RPE from AMD donors had a distinct accumulation of monounsaturated 15-tetracosenoic acid (nervonate; C24:1 (n-9)) and saturated tetracosanoic acid (lignocerate; C24) as well as some C26 and longer lipids, all of which were completely absent in age-matched normal donors.

Conclusions:: 3-Methoxyzeaxanthin and certain very-long-chain fatty acid are biomarkers for age-related ocular disorders in the macula and RPE, respectively. Understanding the underlying mechanisms for the accumulation of these biomarkers will help in elucidating the biochemical mechanisms of AMD pathology.

Keywords: age-related macular degeneration • carotenoids/carotenoid binding proteins • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×